Not every company is slashing its dividend these days. Some of the market's better performers are easing up on their purse strings and sending more money out to their shareholders. So let's take a closer look at some of the companies that inched their payouts higher this past week.

We can start with CVS Caremark (NYSE:CVS). The drugstore chain and prescription fulfiller upped the dosage on its quarterly dividend by 15% to $0.0875 a share.

"This considerable increase reflects our continued strong financial performance, our optimism with respect to future growth, and our significant cash generation capabilities," CFO Dave Denton notes in the announcement.

Linear Technology (NASDAQ:LLTC) is also returning more money to its shareowners. The integrated-circuits specialist's new quarterly rate is $0.23 a share. That's just a $0.01 improvement, but Linear has now jacked up its distributions for 18 consecutive years.

Enterprise Products Partners (NYSE:EPD) is another company fueling its yield, with its quarterly disbursements of $0.56 a share. Some companies, like Linear Technology, crank up their dividends every year, but Enterprise seems to do this every three months. This is the 22nd quarter in a row that finds the midstream energy-services giant boosting its payout.

Finally, we have Fifth Street Finance (NYSE:FSC) banking on its billfold. The corporate lender is increasing its quarterly checks to investors by 11% to $0.30 a share. Yes, even some lenders made it through 2009 in fine fashion.

Some of these moves may not seem like much, but plenty of companies haven't been able to support even their current dividends lately. Associated Banc-Corp (NASDAQ:ASBC) slashed its quarterly payout to a token $0.01 a share.

Subscribers to Income Investor appreciate the companies that send more and more money to their investors. The newsletter service recommends companies that are committed to growing their distributions with market-thumping results.

Want to see what's being recommended these days? Give the newsletter service a shot with a 30-day trial subscription. Who knows? Maybe the next thing to get a boost will be your interest.